Artificial intelligence (AI) is revolutionizing drug discovery by providing novel and efficient ways to identify potential therapeutic compounds. The process of discovering new drugs is […]
Why we should keep an eye on AI in Drug Discovery in 2023
Artificial intelligence (AI) is becoming an increasingly important tool in the field of drug discovery, with the potential to revolutionize the way new drugs are […]
Startup Interview – doceree
As part of the startup Interview series, we are going to interview Mr. Gareth Shaw from Doceree, the first global network of Physician-only platforms for programmatic marketing. Pharmaceutical […]
Startup Interview – Aumet
As part of the startup Interview series, we are going to interview Mr. Mohammed Rababah from Aumet, MENA’s largest B2B Healthcare solution that supports companies with their business […]
Venture Round – Eyenuk, Inc.
On Jul 20, 2021 Eyenuk, Inc. received $6,200,000 financing from AXA Investment Managers and Global Health Investment Fund (GHIF). The company plans to close a […]
Series B – Castor
On Jul 14, 2021, Castor closed a Series B round and raised $45,000,000 from Eight Roads Ventures, F-Prime Capital, INKEF Capital, Two Sigma Ventures, Eight […]
Post-IPO Equity – Adial Pharmaceuticals
On Jul 7, 2021 Adial Pharmaceuticals closed a private placement of 700,001 shares of common stock and raised $5,000,000 from Bespoke Growth Partners, Keystone Capital […]
Series C – Standigm
On Jul 6, 2021, Standigm closed a Series C round and raised $10,000,000 from lead investor Pavilion Capital. About the company: Standigm is located in […]
Series C – TCR Cure
On Jul 1, 2021 TCR Cure closed a Series C round and raised $50,000,000. About the company: TCR Cure is located at China, Asia. “TCRCure […]
Secondary Market – PharmEasy
On Jun 17, 2021 PharmEasy closed a Secondary Market round and raised $20,000,000 featuring lead investor B Capital Group. About the company: PharmEasy is located […]
